Cargando…

The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen

Herein, we report a method of combining bioinformatics and biosensing technologies to select aptamers against prostate specific antigen (PSA). The main objective of this study is to select DNA aptamers with higher binding affinity for PSA by using the proposed method. Based on the five known sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Pi-Chou, Lin, Hui-Ting, Chen, Wen-Yih, Tsai, Jeffrey J. P., Hu, Wen-Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387809/
https://www.ncbi.nlm.nih.gov/pubmed/28459059
http://dx.doi.org/10.1155/2017/5041683
_version_ 1782521016765906944
author Hsieh, Pi-Chou
Lin, Hui-Ting
Chen, Wen-Yih
Tsai, Jeffrey J. P.
Hu, Wen-Pin
author_facet Hsieh, Pi-Chou
Lin, Hui-Ting
Chen, Wen-Yih
Tsai, Jeffrey J. P.
Hu, Wen-Pin
author_sort Hsieh, Pi-Chou
collection PubMed
description Herein, we report a method of combining bioinformatics and biosensing technologies to select aptamers against prostate specific antigen (PSA). The main objective of this study is to select DNA aptamers with higher binding affinity for PSA by using the proposed method. Based on the five known sequences of PSA-binding aptamers, we adopted the functions of reproduction and crossover in the genetic algorithm to produce next-generation sequences for the computational and experimental analysis. RNAfold web server was utilized to analyze the secondary structures, and the 3-dimensional molecular models of aptamer sequences were generated by using RNAComposer web server. ZRANK scoring function was used to rerank the docking predictions from ZDOCK. The biosensors, the quartz crystal microbalance (QCM) and a surface plasmon resonance (SPR) instrument, were used to verify the binding ability of selected aptamer for PSA. By carrying out the simulations and experiments after two generations, we obtain one aptamer that can have the highest binding affinity with PSA, which generates almost 2-fold and 3-fold greater measured signals than the responses produced by the best known DNA sequence in the QCM and SPR experiments, respectively.
format Online
Article
Text
id pubmed-5387809
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-53878092017-04-30 The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen Hsieh, Pi-Chou Lin, Hui-Ting Chen, Wen-Yih Tsai, Jeffrey J. P. Hu, Wen-Pin Biomed Res Int Research Article Herein, we report a method of combining bioinformatics and biosensing technologies to select aptamers against prostate specific antigen (PSA). The main objective of this study is to select DNA aptamers with higher binding affinity for PSA by using the proposed method. Based on the five known sequences of PSA-binding aptamers, we adopted the functions of reproduction and crossover in the genetic algorithm to produce next-generation sequences for the computational and experimental analysis. RNAfold web server was utilized to analyze the secondary structures, and the 3-dimensional molecular models of aptamer sequences were generated by using RNAComposer web server. ZRANK scoring function was used to rerank the docking predictions from ZDOCK. The biosensors, the quartz crystal microbalance (QCM) and a surface plasmon resonance (SPR) instrument, were used to verify the binding ability of selected aptamer for PSA. By carrying out the simulations and experiments after two generations, we obtain one aptamer that can have the highest binding affinity with PSA, which generates almost 2-fold and 3-fold greater measured signals than the responses produced by the best known DNA sequence in the QCM and SPR experiments, respectively. Hindawi 2017 2017-03-28 /pmc/articles/PMC5387809/ /pubmed/28459059 http://dx.doi.org/10.1155/2017/5041683 Text en Copyright © 2017 Pi-Chou Hsieh et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hsieh, Pi-Chou
Lin, Hui-Ting
Chen, Wen-Yih
Tsai, Jeffrey J. P.
Hu, Wen-Pin
The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen
title The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen
title_full The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen
title_fullStr The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen
title_full_unstemmed The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen
title_short The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen
title_sort combination of computational and biosensing technologies for selecting aptamer against prostate specific antigen
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387809/
https://www.ncbi.nlm.nih.gov/pubmed/28459059
http://dx.doi.org/10.1155/2017/5041683
work_keys_str_mv AT hsiehpichou thecombinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen
AT linhuiting thecombinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen
AT chenwenyih thecombinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen
AT tsaijeffreyjp thecombinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen
AT huwenpin thecombinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen
AT hsiehpichou combinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen
AT linhuiting combinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen
AT chenwenyih combinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen
AT tsaijeffreyjp combinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen
AT huwenpin combinationofcomputationalandbiosensingtechnologiesforselectingaptameragainstprostatespecificantigen